Phase I maximum tolerated dose study of RAD 1901 in healthy volunteers

Trial Profile

Phase I maximum tolerated dose study of RAD 1901 in healthy volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 15 Jul 2015

At a glance

  • Drugs Elacestrant (Primary)
  • Indications Advanced breast cancer
  • Focus Adverse reactions; Pharmacokinetics
  • Sponsors Radius Health Inc.
  • Most Recent Events

    • 15 Jul 2015 According to a Radius Health media release, final results of this study are expected in the third quarter of 2015.
    • 15 Jul 2015 Status changed from recruiting to completed according to a Radius Health media release.
    • 11 Dec 2014 Trial design presented at the 37th Annual San Antonio Breast Cancer Symposium.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top